Official UK procurement notice
Cellular Pathology Managed Service Market Engagement
Authority: University Hospitals Birmingham NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionUniversity Hospitals Birmingham NHS Foundation Trust (UHB) is seeking to engage with suppliers interested in its requirement for a Cellular Pathology Managed Service.
Suppliers who are able to offer solutions relevant to this requirement are invited to express an interest and attend a presentation day. Further details on how to do this are contained within the additional information section of this notice.
CPV: Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1The Cellular Pathology Service at University Hospitals Birmingham (UHB) NHS Foundation…Planned
The Cellular Pathology Service at University Hospitals Birmingham (UHB) NHS Foundation Trust is currently situated at the Queen Elizabeth Hospital (QEH) and Heartlands Hospital site, where samples are processed from all UHB locations.
Cellular Pathology at both sites provides a comprehensive diagnostic service to internal users, as well as a variety of external users such as GP’s, none UHB hospitals and some private organisations. The Department processes approximately 100,000 requests a year, the results of which are used for diagnostic and monitoring purposes and in conjunction with other clinical information to direct treatment.
Suppliers who are able to offer services relevant to this requirement are invited to express an interest and attend a presentation day. Further details on how to do this are contained within the additional information section of this notice.
This exercise is intended to provide potential bidders with the opportunity to review the Authority's Briefing Document and to provide information regarding the services they can offer that could meet these outline requirements. This builds on the Authority's commitment to engage with the market, by sharing information and seeking input from the market to enable us to develop the final specification and determine the appropriate route to market in a fair and transparent manner.
Procedure terms & legal framework
From the official record · publisher note attached- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Past planning notice
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 10 Nov 2022, 12:28 GMT
- Last source update
- 10 Nov 2022, 12:28 GMT
- FTS notice number
2022/S 000-031824- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0380c1Find a Tender
Publisher note: Potential suppliers are invited to provide a presentation for the pre-market engagement event to support the procurement of a Cellular Pathology Managed Service Contract on Monday 28 or Tuesday 29 November 2022. This session will be a virtual session hosted via MS Teams. To register your interest in attending, please complete and submit this response form by no later than 09:00 on Monday 21 November 2022. Bravo reference of online form: pqq__28706 - Cellular Pathology Managed Service Market Engagement Direct link to response form: https://nhs.bravosolution.co.uk/go/60612470018460FB3691
How it was run
Official notice- Submission deadline
- —
Timeline
10 Nov 2022 → 1 Sept 2023 · 2 dates- Notice published10 Nov 2022, 12:28 GMT
- Tender notice expected1 Sept 2023, 00:00 BST
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.